10:00 am – 10:08 am:  Oculometric (Eye-Tracking) Profile of Patients on Hydroxychloroquine.  Loh-Shan Bryan Leung, MD

10:08 am – 10:16 am:  Geometric Perfusion Defects (GPD) in Healthy Eyes and Individuals with Diabetic Macular Ischemia.  Mohamed Ibrahim Ahmed, MBBCh, MD, MSc

10:16 am – 10:24 am:  Effect of Presence of Sub-retinal Fluid in Outcome of the Standard or High Dose Ranibizumab for Edema of the Macula in Diabetes in the READ-3 Study.  Amir Hariri, MD

10:24 am – 10:32 am:  Two-Year Results from GATHERS 2.  Michael Ip, MD

10:32 am – 10:40 am:  OAKS DERBY and GALE Updates on Pegcetacoplan.  Scott Walter, MD

10:40 am – 10:48 am:  OCT Guided Visual Function Assessment in Geographic Atrophy Using Custom Algorithms and Microperimetery- Preliminary Findings of the OREO Study.  Yasir J. Sepah, MBBS

10:48 am – 10:56 am:  Inhibition of C1Q for Protection of Visual Function in Patients with Geographic Atrophy: Results of the Phase 2 ARCHER Study with ANX007.  Ted Yednock, PhD

10:56 am – 11:04 am:  The Small Molecule Inhibitors for the cGAS/STING Pathway Regulate the Inflammatory Response during Oxidative Stress-Induced AMD.  David Wan-Cheng Li, PhD

11:04 am – 11:12 am:  ELOVL2 Gene Therapy for Dry AMD: Rationale and Preclinical Data.  Robert B. Bhisitkul, MD, PhD

11:12 am – 11:30 am:  Panel Discussion